Effects of gonadotropin-releasing hormone antagonist (GnRH-ant) cessation on trigger day in a GnRH-ant protocol: a meta-analysis
- PMID: 39731472
- DOI: 10.1080/01443615.2024.2444496
Effects of gonadotropin-releasing hormone antagonist (GnRH-ant) cessation on trigger day in a GnRH-ant protocol: a meta-analysis
Abstract
Background: The gonadotropin-releasing hormone antagonist (GnRH-ant) protocol is associated with few oocytes retrieved, few mature oocytes and poor endometrial receptivity. Omission of GnRH-ants on trigger day seems unlikely to induce preovulation and may improve outcomes in the GnRH-ant protocol. This study aimed to systematically evaluate the effects of GnRH-ant cessation on trigger day on in vitro fertilisation outcomes following the GnRH-ant protocol.
Methods: We searched PubMed, Ovid/MEDLINE, Wanfang, VIP, CNKI and ClinicalTrials.gov databases. The last search was conducted on 10 December 2023 in English or Chinese, without time limitations on the collection of studies from the databases. The references in these articles were manually searched. Randomised controlled trials (RCTs) and cohort studies aimed at assessing the effects of GnRH-ant cessation on trigger day using the GnRH-ant protocol were included. The eligible studies included at least one of the main outcomes: number of oocytes retrieved, proportion of mature oocytes, implantation rate or clinical pregnancy rate.
Results: Three studies with 1449 cycles were included. Cessation of GnRH-ant on trigger day improved the proportion of mature oocytes (odds ratio [OR] = 1.26, 95% confidence interval [CI] = 1.09-1.45, I2 = 0%) but did not affect the number of oocytes retrieved (mean difference [MD] = 0.50, 95% CI = -0.07 to 1.07, I2 = 47%), implantation rate (OR = 0.95, 95% CI = 0.69-1.30, I2 = 0%), clinical pregnancy rate (OR = 1.06, 95% CI = 0.71-1.58, I2 = 0%), endometrial thickness (MD = -0.09, 95% CI = -0.27 to 0.10, I2 = 0%) or cycle cancellation rate (OR = 0.64, 95% CI = 0.15-2.74, I2 = 0%).
Conclusions: Cessation of GnRH-ant on trigger day of the GnRH-ant protocol is suggested because it could improve the proportion of mature oocytes. However, further RCTs are required.
Keywords: GnRH antagonist; clinical outcomes; embryological outcomes; oocyte maturation; ovarian stimulation; trigger day.
Plain language summary
The gonadotropin-releasing hormone antagonist (GnRH-ant) protocol is widely used to treat patients undergoing in vitro fertilisation. However, this protocol is associated with fewer oocytes retrieved, fewer mature oocytes and poorer endometrial receptivity than the depot gonadotropin-releasing hormone agonist protocol. The omission of GnRH-ants on trigger day seems unlikely to induce preovulation and may improve outcomes in the GnRH-ant protocol. This meta-analysis was performed to systematically evaluate the effects of cessation of GnRH-ants on trigger day in in vitro fertilisation outcomes following the GnRH-ant protocol. The cessation of GnRH-ants on trigger day improved the proportion of mature oocytes. It does not compromise the number of oocytes retrieved, implantation rate, clinical pregnancy rate or induction of preovulation. GnRH-ants should be omitted on trigger day of the GnRH-ant protocol during controlled ovarian hyperstimulation.
Similar articles
-
A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial.Hum Reprod. 2024 Sep 1;39(9):1969-1978. doi: 10.1093/humrep/deae145. Hum Reprod. 2024. PMID: 38942602 Clinical Trial.
-
Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves in vitro fertilisation outcomes in poor ovarian responders.J Obstet Gynaecol. 2022 Jul;42(5):1239-1244. doi: 10.1080/01443615.2021.1945560. Epub 2021 Sep 25. J Obstet Gynaecol. 2022. PMID: 34565274
-
Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.Hum Reprod. 2011 Oct;26(10):2742-9. doi: 10.1093/humrep/der240. Epub 2011 Jul 21. Hum Reprod. 2011. PMID: 21778283
-
Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.Sci Rep. 2022 Mar 15;12(1):4456. doi: 10.1038/s41598-022-08400-z. Sci Rep. 2022. PMID: 35292717 Free PMC article.
-
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis.Fertil Steril. 2013 Dec;100(6):1594-601.e1-9. doi: 10.1016/j.fertnstert.2013.08.024. Epub 2013 Sep 19. Fertil Steril. 2013. PMID: 24055048
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources